Found 8 matching trials
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
PHASE2The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
NAThe primary aim of this innovative immunotherapy using WT1/hTERT/Survivin-l...
Location
Department of hematology
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
PHASE1The goal of this research study is to test if the combination of a new T ce...
Location
Beth Israel Deaconess Medical Center
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
PHASE2Acute myelogenous leukemia (AML) arises from leukemia stem cells that are d...
Location
Beth Israel Deaconess Medical Center
DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML
PHASE1The aim of this Phase β
/β
‘ study is to evaluate the safety and efficacy of d...
Location
Department of Hematopoietic Stem Cell Transplantation
Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
PHASE1This research study is studying a cancer vaccine called Dendritic Cell/AML ...
Status
Active Not Recruiting
Location
Beth Israel Deaconess Medical Center
Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
PHASE1Patients with Acute Myelogenous Leukemia (AML) who relapse after an allogen...
Location
University of Louisville
DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
PHASE2This research study is studying a cancer vaccine called Dendritic Cell/AML ...
Status
Active Not Recruiting
Location
Massachusetts General Hospital